Comparison of two assays for molecular determination of rifampin resistance in clinical samples from patients with Buruli ulcer disease

Journal of Clinical Microbiology

Volumn 52, Issue 4, 2014, Pages 1246-1249

  Jansson, Moritz ^a   Beissner, Marcus ^a   Phillips, Richard Odame ^b   Badziklou, Kossi ^c   Piten, Ebekalisai ^d   Maman, Issaka ^c   Sarfo, Fred Stephen ^b   Huber, Kristina Lydia ^a   Rhomberg, Agata ^a   Symank, Dominik ^a   Wagner, Magdalena ^a   Wiedemann, Franz ^e   Nitschke, Jörg ^a,e   Kere, Abiba Banla ^c   Herbinger, Karl Heinz ^a   Adjei, Ohene ^b   Los̈cher, Thomas ^a   Bretzel, Gisela ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^c MINISTÈRE DE LA SANTÉ   (Togo)

^d Centre Hospitalier Régional Maritime CHR Maritime   (Togo)

^e Klinikum der Ludwig Maximilians Universität München   (Togo)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; RIFAMPICIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIUM ISOLATE; BURULI ULCER; CONTROLLED STUDY; GENE SEQUENCE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MYCOBACTERIUM ULCERANS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RPOB GENE; SENSITIVITY ANALYSIS; DRUG EFFECTS; EVALUATION STUDY; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR DIAGNOSIS; PROCEDURES; SENSITIVITY AND SPECIFICITY;

ANTI-BACTERIAL AGENTS; BURULI ULCER; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM ULCERANS; RIFAMPIN; SENSITIVITY AND SPECIFICITY;

EID: 84897144854     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03119-13     Document Type: Article

References (20)

1. Chauty A, Ardant MF, Marsollier L, Pluschke G, Landier J, Adeye A, Goundoté A, Cottin J, Ladikpo T, Ruf T, Ji B. 2011. Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin. Clin. Infect. Dis. 52:94-96. http://dx.doi.org/10.1093/cid/ciq072.
2. Alffenaar JW, Nienhuis WA, de Velde F, Zuur AT, Wessels AM, Almeida D, Grosset J, Adjei O, Uges DR, van der Werf TS. 2010. Pharmacokinetics of rifampin and clarithromycin in patients treated for Mycobacterium ulcerans infection. Antimicrob. Agents Chemother. 54:3878-3883. http://dx.doi.org/10.1128/AAC.00099- 10.
3. Nienhuis WA, Stienstra Y, Thompson WA, Awuah PC, Abass KM, Tuah W, Awua-Boateng NY, Ampadu EO, Siegmund V, Schouten JP, Adjei O, Bretzel G, van der Werf TS. 2010. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial. Lancet 375:664-672. http://dx.doi.org/10.1016/S0140-6736(09)61962-0.
4. Beissner M, Piten E, Maman I, Symank D, Jansson M, Nitschke J, Amekuse K, Kobara B, Wiedemann F, Hoffmann H, Diefenhardt A, Badziklou K, Banla Kere A, Löscher T, Bretzel G. 2012. Spontaneous clearance of a secondary Buruli ulcer lesion emerging ten months after completion of chemotherapy - a case report from Togo. PLoS Negl. Trop. Dis. 6:e1747. http://dx.doi.org/10.1371/ journal.pntd.0001747.
5. Ruf MT, Chauty A, Adeye A, Ardant MF, Koussemou H, Johnson RC, Pluschke G. 2011. Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection? PLoS Negl. Trop. Dis. 5:e1252. http://dx.doi.org/10.1371/journal. pntd.0001252.
6. Gordon CL, Buntine JA, Hayman JA, Lavender CJ, Fyfe JA, Hosking P, Johnson PD. 2011. Spontaneous clearance of Mycobacterium ulcerans in a case of Buruli ulcer. PLoS Negl. Trop. Dis. 5:e1290. http://dx.doi.org/10.1371/journal. pntd.0001290.
7. Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, Matter L, Schopfer K, Bodmer T. 1993. Detection of rifampicinresistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650. http://dx.doi.org/10.1016/0140- 6736(93)90417-F. (Pubitemid 23083244)
8. Honoré N, Cole ST. 1993. Molecular basis of rifampin resistance in Mycobacterium leprae. Antimicrob. Agents Chemother. 37:414-418. http://dx.doi.org/10.1128/AAC.37.3.414. (Pubitemid 23072582)
9. Marsollier L, Honoré N, Legras P, Manceau AL, Kouakou H, Carbonnelle B, Cole ST. 2003. Isolation of three Mycobacterium ulcerans strains resistant to rifampin after experimental chemotherapy of mice. Antimicrob. Agents Chemother. 47:1228-1232. http://dx.doi.org/10.1128/AAC.47.4.1228-1232. 2003. (Pubitemid 36368579)
10. Beissner M, Awua-Boateng NY, Thompson W, Nienhuis WA, Klutse E, Agbenorku P, Nitschke J, Herbinger KH, Siegmund V, Fleischmann E, Adjei O, Fleischer B, van der Werf TS, Löscher T, Bretzel G. 2010. A genotypic approach for detection, identification, and characterization of drug resistance in Mycobacterium ulcerans in clinical samples and isolates from Ghana. Am. J. Trop. Med. Hyg. 83:1059-1065. http://dx.doi.org/10.4269/ajtmh.2010.10-0263.
11. Lee H, Bang HE, Bai GH, Cho SN. 2003. Novel polymorphic region of the rpoB-gene containing Mycobacterium species-specific sequences and its use in identification of Mycobacteria. J. Clin. Microbiol. 41:2213-2218. http://dx.doi.org/10.1128/JCM.41.5.2213-2218.2003. (Pubitemid 36576569)
12. Beissner M, Symank D, Phillips RO, Amoako YA, Awua-Boateng NY, Sarfo FS, Jansson M, Huber KL, Herbinger KH, Battke F, Löscher T, Adjei O, Bretzel G. 2012. Detection of viable Mycobacterium ulcerans in clinical samples by a novel combined 16S rRNA reverse transcriptase/IS2404 real-time qPCR assay. PLoS Negl. Trop. Dis. 6:e1756. http://dx.doi.org/10.1371/journal.pntd.0001756.
13. Fyfe JA, Lavender CJ, Johnson PD, Globan M, Sievers A, Azuolas J, Stinear TP. 2007. Development and application of two multiplex realtime PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samples. Appl. Environ. Microbiol. 73:4733-4740. http://dx.doi.org/10.1128/AEM.02971-06. (Pubitemid 47241073)
14. Kim BJ, Lee SH, Lyu MA, Kim SJ, Bai GH, Chae GT, Kim EC, Cha CY, Kook YH. 1999. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J. Clin. Microbiol. 37:1714-1720. (Pubitemid 29235212)
15. Kim BJ, Lee KH, Park BN, Kim SJ, Bai GH, Kim SJ, Kook YH. 2001. Differentiation of mycobacterial species by PCR-restriction analysis of DNA (342 base pairs) of the RNA polymerase gene (rpoB). J. Clin. Microbiol. 39:2102-2109. http://dx.doi.org/10.1128/JCM.39.6.2102-2109.2001.
16. Gingeras TR, Ghandour G, Wang E, Berno A, Small PM, Drobniewski F, Alland D, Desmond E, Holodniy M, Drenkow J. 1998. Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res. 8:435-448. (Pubitemid 28256794)
17. Bretzel G, Huber KL, Kobara B, Beissner M, Piten E, Herbinger KH, Wiedemann FX, Amekuse K, Banla Kere A, Helfrich K, Fleischmann E, Löscher T, Diefenhardt A, Nitschke J. 2011. Laboratory confirmation of Buruli ulcer disease in Togo. PLoS Negl. Trop. Dis. 5:e1228. http://dx.doi.org/10.1371/ journal.pntd.0001228.
18. Beissner M, Huber KL, Badziklou K, Halatoko WA, Maman I, Vogel F, Bidjada B, Awoussi KS, Piten E, Helfrich K, Mengele C, Nitschke J, Amekuse K, Wiedemann FX, Diefenhardt A, Kobara B, Herbinger KH, Banla Kere A, Prince-David M, Löscher T, Bretzel G. 2013. Implementation of a national reference laboratory for Buruli ulcer disease in Togo. PLoS Negl. Trop. Dis. 7:e2011. http://dx.doi.org/10.1371/journal.pntd.0002011.
19. World Health Organization 2010. Guidance on sampling techniques for laboratory-confirmation of Mycobacterium ulcerans infection (Buruli ulcer disease). World Health Organization, Geneva, Switzerland.
20. Li W, Matsuoka M, Kai M, Thapa P, Khadge S, Hagge DA, Brennan PJ, Vissa V. 2012. Real-time PCR and high-resolution melt analysis for rapid detection of Mycobacterium leprae drug resistance mutations and strain types. J. Clin. Microbiol. 50:742-753. http://dx.doi.org/10.1128/JCM.05183-11.